Monograph Details
|
|
Immune System
> Immunization
|
|
FLUVIRIN |
| Manufacturer |
|
Chiron Corporation |
| Legal Classification |
|
Rx
|
| Generic Name |
|
Trivalent inactivated "split virus" influenza vaccine (Types A and B); formulation changes annually; susp for IM inj; contains thimerosal. |
| Indications |
|
Influenza immunization. |
| Adults and Children |
|
Each dose is 0.5mL IM. <4yrs: not recommended. 4–8yrs: 2 doses at least 1 month apart for 1st immunization, otherwise 1 dose per season. >9yrs: 1 dose/season. Infants and young children: give in anterolateral thigh; older: give in deltoid muscle. |
| Contraindications |
|
Allergy to egg or chicken proteins. Life-threatening reaction to any previous flu vaccine. Active neurologic disorder (may administer after stabilized). Acute febrile illness. |
| Precautions |
|
Use current formulation only. Have epinephrine inj (1:1000) available. Guillain-Barre syndrome within 6 weeks of previous flu vaccine. Bleeding disorders. Immunosuppressed. Pregnancy (Cat.C). Nursing mothers. |
| Interactions |
|
Concomitant vaccines: insufficient data (see literature). Immunosuppressants (eg, irradiation, antimetabolites, alkylating agents, corticosteroids, cytotoxic drugs) may result in suboptimal response. May potentiate warfarin, theophylline. |
| Adverse Reactions |
|
Local reactions, fever, malaise, myalgia. |
| How Supplied |
|
Multidose vial (5mL)—1 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
